Medinet Co., Ltd. Reports Consolidated Earnings Results for the Year Ended September 30, 2020
November 13, 2020 at 01:00 am EST
Share
MEDINET Co., Ltd. reports consolidated earnings results for the year ended September 30, 2020. For the year, the company reported net sales of JPY 783 million compared to JPY 1,059 million a year ago. Operating loss was JPY 926 million compared to JPY 1,008 million a year ago. Ordinary loss was JPY 836 million against JPY 995 million a year ago. Loss was JPY 842 million compared to JPY 795 million a year ago. Basic loss per share was JPY 6.19 compared to JPY 6.71 a year ago.
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
MEDINET CO., LTD. 
